ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Selenium Status in Patients with Chronic Liver Disease: A Systematic Review and Meta-Analysis

Lin, Yaduan; He, Fanchen; Lian, Shaoyan; Xie, Binbin; Liu, Ting; He, Jiang*; Liu, Chaoqun*南方医科大学
OncoImmunology2022-3DOI: 10.3390/nu14050952
7被引9阅读
引用收藏
分享

摘要

Background: The potential role of selenium in preventing chronic liver diseases remains controversial. This meta-analysis aimed to summarize the available evidence from observational studies and intervention trials that had evaluated the associations between body selenium status and chronic liver diseases. Methods: We comprehensively searched MEDLINE, Embase, Web of Science, and Cochrane Library from inception to April 2021. The study protocol was registered at PROSPERO (CRD42020210144). Relative risks (RR) for the highest versus the lowest level of selenium and standard mean differences (SMD) with 95% confidence intervals (CI) were pooled using random-effects models. Heterogeneity and publication bias were evaluated using the I-2 statistic and Egger's regression test, respectively. Results: There were 50 studies with 9875 cases and 12975 population controls in the final analysis. Patients with hepatitis (SMD = -1.78, 95% CI: -2.22 to -1.34), liver cirrhosis (SMD = -2.06, 95% CI: -2.48 to -1.63), and liver cancer (SMD = -2.71, 95% CI: -3.31 to -2.11) had significantly lower selenium levels than controls, whereas there was no significant difference in patients with fatty liver diseases (SMD = 1.06, 95% CI: -1.78 to 3.89). Moreover, the meta-analysis showed that a higher selenium level was significantly associated with a 41% decrease in the incidence of significant advanced chronic liver diseases (RR = 0.59, 95% CI: 0.49 to 0.72). Conclusion: Our meta-analysis suggested that both body selenium status and selenium intake were negatively associated with hepatitis, cirrhosis, and liver cancer. However, the associations for fatty liver diseases were conflicting and need to be established in prospective trials.

学科与关键词

关键词
seleniumchronic liver diseasefatty liver diseaseshepatitiscirrhosisliver cancerselenium intakemeta-analysis
相关
加载中…
  • Association between blood heavy metal exposure levels and risk of metabolic dysfunction associated fatty liver disease in adults: 2015-2020 NHANES large cross-sectional study
    Tang, Song; Luo, Simin; Wu, Zhendong; Su, Jiandong*Frontiers in Public Health, 2024, 12: 1280163.
  • Association of Plasma Selenium and Its Untargeted Metabolomic Profiling with Cervical Cancer Prognosis
    Qi, Lei; Wang, Yuanyuan; Wang, Ruixiang; Wang, Mingxing; Jablonska, Ewa; Zhou, Huihui; Su, Shengqi; Jia, Yuehui; Zhang, Yiyi; Li, Qi*; Wang, Tong*Biological Trace Element Research, 2023, 201(10): 4637-4648.
  • Association of circulating selenium concentration with dyslipidemia: Results from the NHANES
    Huang, Yu-qing; Shen, Geng; Lo, Kenneth; Huang, Jia-yi; Liu, Lin; Chen, Chao-lei; Yu, Yu-ling; Sun, Shuo; Zhang, Bin*; Feng, Ying-qing*Journal of Trace Elements in Medicine and Biology, 2020, 58: 126438.被引 24
查看全部 →

发表信息

论文状态
公开发表
期刊
OncoImmunology
发表日期
2022-03
卷期
第 14 卷, 第 5 期
页码
952
DOI
10.3390/nu14050952
语言
ENGLISH
期刊收录
SCIE
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81903294]; Natural Science Foundation of Guangdong Province [2018030310412]

作者

  • L

    Lin, Yaduan (第一作者)

  • H

    He, Fanchen

查看全部 7 位作者收起作者
  • L

    Lian, Shaoyan

  • X

    Xie, Binbin

  • L

    Liu, Ting

  • H

    He, Jiang (通讯)

    southern med univ

  • L

    Liu, Chaoqun (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417